1. Ahvazi, B.C., Jacobs, P. & Stevenson, M.M. (1995) Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria. J. Leukoc. Biol., 58, 23-31.
2. Amet, S., Zimner-Rapuch, S., Launay-Vacher, V., Janus, N. & Deray, G. (2013) Malaria prophylaxis in patients with renal impairment: a review. Drug Saf., 36, 83-91.
3. Awab, G.R., Pukrittayakamee, S., Imwong, M., Dondorp, A.M., Woodrow, C.J., Lee, S.J., Day, N.P., Singhasivanon, P., White, N.J. & Kaker, F. (2010) Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial. Malar. J., 9, 105.
4. Baird, J.K. (2004) Chloroquine resistance in Plasmodium vivax. Antimicrob. Agents Chemother., 48, 4075-4083.
5. Baird, J.K. (2009) Resistance to therapies for infection by Plasmodium vivax. Clin. Microbiol. Rev., 22, 508-534.